Raiffeisen Bank International AG
BankPosition in ALLO — Allogene Therapeutics, Inc.
CIK 2044885
VIENNA, C4
Position in ALLO
as of Mar 31, 2026
· filed Apr 24, 2026
Position Value
$1,708,000
+$475,000 QoQ
Shares Held
700,000
-22.2% QoQ
Ownership
0.203%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALLO Over Time
Shares Held
Position Value (USD)
Derivatives in ALLO
reported options exposure · as of Mar 31, 2026CallValue
$4,880
CallShares
2,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Raiffeisen Bank International AG holds $97,826,369 across 28 Biotechnology names. ALLO ranks #10 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
101,435 | $45,294,784 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
23,203 | $17,927,565 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
10,413 | $3,445,349 | |
| 4 | BNTX |
BioNTech SE
|
35,000 | $3,110,800 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
36,000 | $2,703,240 | |
| 6 | LEGN |
Legend Biotech Corp
|
140,000 | $2,532,600 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
26,000 | $2,528,500 | |
| 8 | RLAY |
Relay Therapeutics, Inc.
|
190,000 | $1,890,500 |
All Filings in ALLO
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,880 | 2,000 | Call | Sole | 2026-04-24 | |
| 2026-03-31 | $1,708,000 | 700,000 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $2,740 | 2,000 | Call | Sole | 2026-02-12 | |
| 2025-12-31 | $1,233,000 | 900,000 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,480 | 2,000 | Call | Sole | 2025-11-10 | |
| 2025-09-30 | $558,000 | 450,000 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $454,260 | 402,000 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $586,920 | 402,000 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $915,900 | 430,000 | Shares | Defined | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||